Premium
Definitive radiotherapy in the management of paragangliomas arising in the head and neck: A 35‐year experience
Author(s) -
Hinerman Russell W.,
Amdur Robert J.,
Morris Christopher G.,
Kirwan Jessica,
Mendenhall William M.
Publication year - 2008
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.20885
Subject(s) - medicine , radiosurgery , radiation therapy , head and neck , radiology , paraganglioma , incidence (geometry) , surgery , physics , optics
Background. An evaluation of the treatment results for 104 patients with 121 paragangliomas of the temporal bone, carotid body, and/or glomus vagale who were treated with radiation therapy (RT) at the University of Florida between 1968 and 2004. Methods. Eighty‐nine paragangliomas (86%) were treated with conventional megavoltage techniques, 15 (14%) patients with stereotactic fractionated radiation therapy, 6 (6%) patients with stereotactic radiosurgery (SRS), and 11 (11%) patients with intensity‐modulated radiation therapy (IMRT). Results. There were 6 local recurrences. One recurrence was salvaged with additional RT. The actuarial local control and cause‐specific survival rates at 10 years were 94% and 95%. The overall local control rate for all 121 lesions was 95%; the ultimate local control rate was 96%. The incidence of treatment‐related complications was low. Conclusion. Fractionated RT offers a high probability of tumor control with minimal risks for patients with paragangliomas of the temporal bone and neck. © 2008 Wiley Periodicals, Inc. Head Neck, 2008
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom